Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value
about
The role of MRI in prostate cancer diagnosis and management.Integration of multiparametric MRI into active surveillance of prostate cancer.Multi-parametric magnetic resonance imaging as a management decision tool.Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.Difference of opinion - Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: Yes.Risk Stratification Among Men With Prostate Imaging Reporting and Data System Version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?Prostate cancer risk stratification with magnetic resonance imaging.Opportunities for multiparametric MRI with PI-RADS v2 to make a difference.Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population.MR/US Fusion Technology: What Makes It Tick?Prostatic intraepithelial neoplasia-like ductal prostatic adenocarcinoma: A case suitable for active surveillance?Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate CancerValue of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance.3D T2-weighted imaging to shorten multiparametric prostate MRI protocols.The role of whole-lesion apparent diffusion coefficient analysis for predicting outcomes of prostate cancer patients on active surveillance.Repeat multiparametric MRI in prostate cancer patients on active surveillance.Targeted Prostate Biopsy in the Era of Active Surveillance.Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer.Quality of care and economic considerations of active surveillance of men with prostate cancer.Imaging for the selection and monitoring of men on active surveillance for prostate cancer.Entering an era of radiogenomics in prostate cancer risk stratificationMRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
P2860
Q30245245-FBA2207A-79FF-46FE-9C7C-F09402D5A27CQ30249514-216A8207-0289-4757-8B9B-CF27E0348532Q33890160-006E9744-EBCA-4D25-83EF-1FECF348875AQ37029385-B5D56C3F-9FBD-48A7-A13C-E6E67B0F1BD5Q37037017-87D49AC5-BF1A-4A77-9182-A4F09FD449F2Q38600043-F1883F31-D4C3-46F4-86DF-8343B174C2F9Q38796980-A186A066-8637-49E3-A524-87BACD9E6F79Q38820008-94C6DD44-101C-46F6-B68C-1B6FD43FB6EAQ38989771-899DA2E9-8688-444B-B7CD-FCB9401638D9Q39148879-1CAB2415-FFC9-48B5-92B7-86DFFD948227Q41902458-6787BD49-D698-403D-8BC9-3783B100D0C3Q42374568-41C6B300-4267-4B57-8F59-13442969E88BQ46194986-728C6283-61F3-46DE-AC1E-068473BC7014Q47149516-59E102A7-1ADC-4158-B131-6B662A8BA31AQ47603123-B332C1EA-8BD1-43A6-AC30-9BA455B318C4Q48293477-ABB0BFC6-E307-4D42-9C26-79319CC93F6AQ48342579-8DB3CCD6-59A5-4A16-B336-072DE223BF06Q48527660-E68C36BE-A8E8-4A24-B4A7-BC3C4450B061Q55025747-EC5E92B9-7212-43D2-9D24-82A4DADA8E8AQ55253463-53C9D641-DAD5-44DD-A2D0-19FF3C74CDF2Q55259128-58FB2883-05CF-41F5-875B-1AC35F04E95FQ58562049-C2D65CC8-61BB-4449-A68F-9AE67015E7BBQ58562086-C87C60E4-4CF7-4589-9C06-D47B1E9B74D5
P2860
Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serial Magnetic Resonance Imag ...... tate Cancer: Incremental Value
@en
type
label
Serial Magnetic Resonance Imag ...... tate Cancer: Incremental Value
@en
prefLabel
Serial Magnetic Resonance Imag ...... tate Cancer: Incremental Value
@en
P2093
P2860
P1476
Serial Magnetic Resonance Imag ...... tate Cancer: Incremental Value
@en
P2093
Daniel J Margolis
Ely R Felker
Fred Dorey
Jiaoti Huang
Leonard S Marks
Shyam Natarajan
Steven S Raman
P2860
P304
P356
10.1016/J.JURO.2015.11.055
P407
P577
2015-12-07T00:00:00Z